Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomics

BACKGROUND: The heat shock protein 90 (Hsp90) is required for the stability of many signalling kinases. As a target for cancer therapy it allows the simultaneous inhibition of several signalling pathways. However, its inhibition in healthy cells could also lead to severe side effects. This is the fi...

Descripción completa

Detalles Bibliográficos
Autores principales: Haupt, Armin, Joberty, Gerard, Bantscheff, Marcus, Fröhlich, Holger, Stehr, Henning, Schweiger, Michal R, Fischer, Axel, Kerick, Martin, Boerno, Stefan T, Dahl, Andreas, Lappe, Michael, Lehrach, Hans, Gonzalez, Cayetano, Drewes, Gerard, Lange, Bodo MH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342885/
https://www.ncbi.nlm.nih.gov/pubmed/22277058
http://dx.doi.org/10.1186/1471-2407-12-38

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342885/
https://www.ncbi.nlm.nih.gov/pubmed/22277058
http://dx.doi.org/10.1186/1471-2407-12-38

Ejemplares similares